I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasma cell | 11 studies | 32% ± 10% | |
| plasmablast | 8 studies | 37% ± 24% | |
| endothelial cell | 5 studies | 24% ± 8% | |
| ciliated cell | 5 studies | 26% ± 5% | |
| pancreatic A cell | 4 studies | 43% ± 8% | |
| classical monocyte | 4 studies | 22% ± 6% | |
| conventional dendritic cell | 4 studies | 23% ± 6% | |
| epithelial cell | 4 studies | 41% ± 9% | |
| plasmacytoid dendritic cell | 4 studies | 23% ± 6% | |
| type B pancreatic cell | 3 studies | 50% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 16% ± 1% | |
| hematopoietic precursor cell | 3 studies | 25% ± 7% | |
| non-classical monocyte | 3 studies | 25% ± 7% | |
| enterocyte | 3 studies | 20% ± 4% | |
| fibroblast | 3 studies | 25% ± 9% | |
| macrophage | 3 studies | 23% ± 4% | |
| glutamatergic neuron | 3 studies | 26% ± 7% | |
| dendritic cell | 3 studies | 36% ± 8% | |
| natural killer cell | 3 studies | 19% ± 3% | |
| enteroendocrine cell | 3 studies | 26% ± 11% | |
| basal cell | 3 studies | 28% ± 10% |
